| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Found in roots, leaves, nut-hulls, bark and wood of walnut trees. Juglone (5-hydroxy-1,4-naphthoquinone) Juglans nigra refers to the black walnut tree, which is one of the most well-known sources of juglone -Research has focused on the hulls (the green outer covering of the walnut) because they have the highest concentrations. -Fresh hulls can contain juglone levels in the range of approximately 1–5% of the dry weight -Juglone can redox cycle to generate reactive oxygen species (ROS). -Increasing Bax, decreasing Bcl‑2, caspase activation, and MMP depolarization. -Modulation of MAPK pathways (including ERK, JNK, and p38) -May inhibit NF‑κB signaling -Cause DNA damage or stress that, in turn, leads to p53 pathway activation— Pin1 Inhibition –Pin1, a peptidyl-prolyl cis/trans isomerase, is frequently overexpressed in cancer. -ic50 maybe 5-10uM -For matching 5uM, crude estimate is 5mg consumption of juglone required which might be 1.5 g of black walnut hull material
|
| Source: HalifaxProj(activate) |
| Type: |
| Autophagy genes, including Atg3, Atg5, Atg6, Atg7, Atg10, Atg12, and Atg17. Tumor autophagy refers to the process by which cancer cells degrade and recycle cellular components through autophagy, a cellular mechanism that helps maintain homeostasis and respond to stress. Autophagy can have dual roles in cancer, acting as both a tumor suppressor and a promoter, depending on the context. Authophagy is the process used by cancer cells to “self-eat” to survive. Authophagy can be both good and bad. If authophagy is prolonged this will become a lethal process to cancer. On the other hand, for a short while (e.g. during chemotheraphy, radiotheraphy, etc.) authophagy is used by cancer cells to survive. For example, Chloroquine is a blocker of autophagy and has been used in a lab setting to dramatically enhance tumor response to radiotherapy, chemotherapy. |
| 5118- | JG, | Juglone induces apoptosis and autophagy via modulation of mitogen-activated protein kinase pathways in human hepatocellular carcinoma cells |
| - | in-vitro, | HCC, | HepG2 |
| 5117- | JG, | https://pubmed.ncbi.nlm.nih.gov/31283929/ |
| - | vitro+vivo, | Liver, | NA |
| 1918- | JG, | ROS -mediated p53 activation by juglone enhances apoptosis and autophagy in vivo and in vitro |
| - | in-vitro, | Liver, | HepG2 | - | in-vivo, | NA, | NA |
| 1917- | JG, | Inhibition of human leukemia cells growth by juglone is mediated via autophagy induction, endogenous ROS production, and inhibition of cell migration and invasion |
| - | in-vitro, | AML, | HL-60 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:105 Target#:321 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid